IL6 and neoplasm: Overexpression of IL-1β leads to enhanced metastasis (one of the major causes of adverse prognosis in patients with advanced OSCC) through secretion of oncogenic cytokines IL-6, IL-8, and GRO-α (growth-regulated oncogene α) by tumor cells [70].